Register now for Pharmacology Update 2020: Webinar & Kick-off Zoom Meeting. Why? You probably don’t even know what ‘costimulated autologous T cells’ are!
Posted almost 5 years ago by Elaine Crain
Aaron P. Rapoport, MD Is a board-certified hematologist and stem cell transplant physician with more than 25 years of experience in the care of patients with hematopoietic neoplasms and benign hematologic disorders. He has conducted translational research focused on the use of costimulated autologous T cells and vaccines to enhance immune recovery after autologous stem cell transplants for hematologic malignancies. Between 1998 and 2015, he directed 6 major clinical trials of adoptive T-cell therapy that have enrolled more than 150 patients. His group was among the first to show that combination immunotherapy using vaccine-primed and ex vivo costimulated autologous T cells could induce robust vaccine-specific immune responses early after autologous stem cell transplantation (ASCT) for myeloma.
This education activity has been submitted to the American Association of Nurse Practitioners for approval of 7.0 contact hours of continuing education (which includes 6.6 hours pharmacology).
Registration is open and the webinar will go live on October 3, 2020
We are also proud to welcome back our Industry and Pharmaceutical partners with the construction of a virtual exhibit hall. Stay tuned!
We also offer 13 additional CEs with a focus on pharmacology at MAAPConline.org
Pearls of Practice 8
Opioids, They're a Pain*
Pharmacologic Management of Withdrawal, Addiction and Acute Pain*
The NP Virtual CE Summit (Coming in November 2020)
(* meet the safe prescribing of opiates requirement under COMAR)
Join MAAPC or CBANACNS and save $112 ($8 per CE)
Questions? Contact Lorraine Diana & Gena Stanek at TheMAAPC@gmail.com